kt 5823 has been researched along with cyclic adp-ribose in 1 studies
Studies (kt 5823) | Trials (kt 5823) | Recent Studies (post-2010) (kt 5823) | Studies (cyclic adp-ribose) | Trials (cyclic adp-ribose) | Recent Studies (post-2010) (cyclic adp-ribose) |
---|---|---|---|---|---|
317 | 0 | 59 | 758 | 0 | 144 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clementi, E; Meldolesi, J; Nisticò, G; Riccio, M; Sciorati, C | 1 |
1 other study(ies) available for kt 5823 and cyclic adp-ribose
Article | Year |
---|---|
The type 2 ryanodine receptor of neurosecretory PC12 cells is activated by cyclic ADP-ribose. Role of the nitric oxide/cGMP pathway.
Topics: Adenosine Diphosphate Ribose; Alkaloids; Animals; Biomarkers; Caffeine; Calcium; Calcium Channels; Carbazoles; Cyclic ADP-Ribose; Cyclic GMP; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Indoles; Ionomycin; Muscle Proteins; Neurosecretory Systems; Nitric Oxide; Nitroprusside; PC12 Cells; Penicillamine; Rats; Ryanodine Receptor Calcium Release Channel; S-Nitroso-N-Acetylpenicillamine; Signal Transduction; Terpenes; Thapsigargin | 1996 |